Lannett (LCI) Reports Prelim. Q4 Results, Provides Update On Contract Renewal

Go back to Lannett (LCI) Reports Prelim. Q4 Results, Provides Update On Contract Renewal

Raymond James Downgrades Lannett Co (LCI) to Market Perform

August 20, 2018 2:19 PM EDT

Raymond James analyst Elliot Wilbur downgraded Lannett Co (NYSE: LCI) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Lannett Co click here. For more ratings news on Lannett Co click here.

Shares of Lannett Co closed at $13.50 yesterday.

... More

Lannett Co (LCI) PT Lowered to 'Street Low' $5 at Deutsche Bank

August 20, 2018 1:46 PM EDT

Deutsche Bank analyst Gregg Gilbert lowered the price target on Lannett Co (NYSE: LCI) to a street low $5.00 (from $20.00) while maintaining a Hold rating amid news the contract with Jerome Stevens Pharmaceuticals (JSP) will not be renewed.

"Our new target... More

Craig-Hallum Downgrades Lannett Co (LCI) to Neutral

August 20, 2018 12:57 PM EDT

Craig-Hallum analyst Matthew Hewitt downgraded Lannett Co (NYSE: LCI) from Buy to Neutral with a price target of $7.00.

The analyst said the end of the JSP relationship creates a noticeable cash flow void.

For an analyst ratings summary and ratings... More